Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb;20(2):398-415.
doi: 10.1097/01.MIB.0000435441.30107.8b.

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States

Millie D Long  1 , Susan Hutfless, Michael D Kappelman, Hamed Khalili, Gilaad G Kaplan, Charles N Bernstein, Jean Frederic Colombel, Corinne Gower-Rousseau, Lisa Herrinton, Fernando Velayos, Edward V Loftus Jr, Geoffrey C Nguyen, Ashwin N Ananthakrishnan, Amnon Sonnenberg, Andrew Chan, Robert S Sandler, Ashish Atreja, Samir A Shah, Kenneth J Rothman, Neal S Leleiko, Renee Bright, Paolo Boffetta, Kelly D Myers, Bruce E Sands
Affiliations
Review

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States

Millie D Long et al. Inflamm Bowel Dis. 2014 Feb.

Abstract

This review describes the history of U.S. government funding for surveillance programs in inflammatory bowel diseases (IBD), provides current estimates of the incidence and prevalence of IBD in the United States, and enumerates a number of challenges faced by current and future IBD surveillance programs. A rationale for expanding the focus of IBD surveillance beyond counts of incidence and prevalence, to provide a greater understanding of the burden of IBD, disease etiology, and pathogenesis, is provided. Lessons learned from other countries are summarized, in addition to potential resources that may be used to optimize a new form of IBD surveillance in the United States. A consensus recommendation on the goals and available resources for a new model for disease surveillance are provided. This new model should focus on "surveillance of the burden of disease," including (1) natural history of disease and (2) outcomes and complications of the disease and/or treatments.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biopsychosocial model of inflammatory bowel disease prognosis
Figure 2
Figure 2
Important Components of an Inflammatory Bowel Disease Surveillance System in the United States
See this image and copyright information in PMC

References

    1. Kappelman MD, Rifas-Shiman SL, Porter CQ, Ollendorf DA, Sandler RS, Galanko JA, Finkelstein JA. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907–13. - PMC - PubMed
    1. Park KT, Bass D. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review. Inflamm Bowel Dis. 2011;17:1603–9. - PubMed
    1. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–9. - PubMed
    1. Loftus CG, Loftus EV, Jr., Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ, 3rd, Sandborn WJ. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13:254–61. - PubMed
    1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. e42. quiz e30. - PubMed

Publication types

MeSH terms